# IV Colistin for Pulmonary Exacerbations: Improving Safety and Efficacy

> **NCT02918409** · PHASE4 · COMPLETED · sponsor: **National Jewish Health** · enrollment: 51 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Colistin
- **DRUG:** Tobramycin

## Key facts

- **NCT ID:** NCT02918409
- **Lead sponsor:** National Jewish Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-26
- **Primary completion:** 2020-09-10
- **Final completion:** 2021-11-22
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02918409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02918409, "IV Colistin for Pulmonary Exacerbations: Improving Safety and Efficacy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02918409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*